Pain Management Nursing
- Rois Narvaez
- Mar 1
- 13 min read
š„ Pain Management Nursing
Pain is a multidimensional sensory and emotional experience associated with actual or potential tissue damage. It involves complex physiologic pathways, psychological interpretation, and individual variability influenced by culture, cognition, and past experiences. Effective pain management is a core nursing responsibility that directly impacts recovery, mobility, respiratory function, and overall patient outcomes. Nurses must integrate pathophysiology, assessment tools, pharmacology, and non-pharmacologic strategies to provide safe, individualized, and evidence-based pain control.
1ļøā£ š„ Pain Physiology
𧬠Pathophysiology (What Happens in the Body)
š· Tissue injury releases prostaglandins + bradykinin
š· Inflammation ā nociceptor sensitivity
š· A-delta fibers transmit sharp localized pain
š· C fibers transmit dull aching pain
š· Signal travels spinal cord ā brain cortex
š· Endorphins naturally suppress pain transmission
š Clinical Presentation (How the Patient Experiences It)
š· Sharp stabbing pain = fast A-delta activation
š· Dull throbbing pain = slow C fiber response
š· Inflammation causes redness + swelling + tenderness
š· Anxiety ā perceived pain intensity
š· Fatigue lowers pain tolerance threshold
š· Cultural background influences pain expression
𩺠Nursing Assessment (What We Look For)
š· Numeric pain scale 0ā10 rating
š· Location + quality + duration description
š· Vital signs HR ā BP ā may indicate pain
š· Guarding or facial grimacing observed
š· Sleep disturbance associated with uncontrolled pain
š· Reassess 30ā60 minutes after intervention
š Management Principles (How We Control It)
š· NSAIDs (ibuprofen) block prostaglandin production
š· Opioids (morphine, fentanyl) act on mu receptors
š· Multimodal therapy ā total opioid requirement
š· Positioning + splinting reduces incisional pain
š· Relaxation breathing ā sympathetic stimulation
š· Early intervention prevents pain escalation
2ļøā£ š„ Types of Pain
𧬠Pathophysiology (Mechanism Type)
š· Nociceptive pain = tissue injury or inflammation
š· Neuropathic pain = nerve damage or dysfunction
š· Acute pain protective + short duration
š· Chronic pain persists >3 months duration
š· Visceral pain diffuse poorly localized
š· Somatic pain well localized sharp sensation
š Clinical Presentation (Patient Experience)
š· Acute pain sudden onset after injury
š· Chronic pain persistent daily discomfort
š· Neuropathic pain burning shooting electric sensation
š· Visceral pain cramping deep pressure quality
š· Referred pain felt distant from source
š· Breakthrough pain sudden severe flare episode
𩺠Nursing Assessment (What to Differentiate)
š· Identify onset sudden vs gradual pattern
š· Ask quality sharp dull burning throbbing
š· Determine duration acute vs chronic timeline
š· Assess radiation or referred distribution
š· Evaluate functional limitation due to pain
š· Screen emotional impact anxiety depression
š Management Principles (Treatment Direction)
š· Acute pain treat underlying cause promptly
š· Chronic pain requires long-term multimodal plan
š· Neuropathic pain responds to gabapentin duloxetine
š· Nociceptive pain responds to NSAIDs opioids
š· Breakthrough pain treated with short-acting opioid
š· Combine pharmacologic + non-pharmacologic strategies
3ļøā£ š„ Pain Assessment Tools & Scales
𧬠Clinical Purpose
š· Standardized scales ensure objective pain documentation
š· Consistent scoring improves treatment comparison
š· Baseline score guides medication selection
š· Reassessment measures intervention effectiveness
š· Required for safe opioid administration
š· Supports legal documentation accuracy
š Clinical Application
š· Numeric Rating Scale 0ā10 most common
š· Wong-Baker Faces useful pediatric patients
š· FLACC scale used nonverbal patients
š· CPOT used in ICU ventilated patients
š· Visual Analog Scale measures pain continuum
š· Behavioral cues supplement verbal report
𩺠Nursing Assessment
š· Assess before and after analgesic administration
š· Reassess 30ā60 minutes post medication
š· Document location quality intensity duration
š· Observe guarding grimacing restlessness
š· Compare score trends not single value
š· Evaluate functional impact sleep mobility
š Management Integration
š· Score 1ā3 mild pain treat non-opioid
š· Score 4ā6 moderate pain consider opioid adjunct
š· Score 7ā10 severe pain strong opioid indicated
š· Persistent high score requires escalation
š· Multimodal therapy improves control
š· Adjust plan based on reassessment findings
4ļøā£ š„ Comprehensive Pain Assessment (PQRST Framework)
𧬠Framework Components
š· P = provoking or relieving factors
š· Q = quality sharp dull burning
š· R = region or radiation pattern
š· S = severity scale 0ā10
š· T = timing onset duration frequency
š· Expands beyond simple numeric scoring
š Clinical Application
š· Identify activity worsening incisional pain
š· Determine if pain radiates to shoulder jaw
š· Assess if pain intermittent or constant
š· Evaluate nighttime worsening patterns
š· Clarify effect of movement or coughing
š· Distinguish visceral vs somatic description
𩺠Nursing Assessment
š· Ask open-ended questions encourage detail
š· Avoid leading questions about intensity
š· Validate patient report regardless appearance
š· Assess impact on appetite and sleep
š· Identify psychosocial stressors influencing pain
š· Document findings clearly and consistently
š Management Integration
š· Provoking factor removal reduces pain stimulus
š· Timing guides medication scheduling not PRN only
š· Severe constant pain may require around-the-clock dosing
š· Radiation pattern may signal complication
š· Unrelieved pain prompts provider notification
š· Individualized plan improves patient satisfaction
5ļøā£ š„ Cultural & Psychosocial Influences on Pain
𧬠Psychologic Mechanisms
š· Anxiety ā sympathetic activation and pain perception
š· Depression lowers pain tolerance threshold
š· Fear amplifies cortical pain interpretation
š· Catastrophizing increases perceived intensity
š· Previous trauma influences pain memory
š· Stress hormones ā inflammatory response
š Cultural Expression
š· Some cultures minimize verbal pain expression
š· Others openly express discomfort behaviorally
š· Stoicism ā absence of pain
š· Family expectations influence reporting
š· Spiritual beliefs affect coping mechanisms
š· Language barriers complicate assessment accuracy
𩺠Nursing Assessment
š· Ask patient preferred pain expression style
š· Avoid stereotyping based on ethnicity
š· Assess nonverbal cues carefully
š· Use certified interpreter if needed
š· Identify support systems availability
š· Screen for anxiety or depression
š Management Considerations
š· Provide culturally sensitive education
š· Encourage realistic pain control expectations
š· Involve family appropriately in care
š· Combine relaxation with medication therapy
š· Address anxiety before escalating opioids
š· Build trust to improve pain reporting
6ļøā£ š„ Pharmacology of Non-Opioid Analgesics
𧬠Mechanism of Action
š· NSAIDs inhibit COX enzyme ā prostaglandins
š· Acetaminophen acts centrally reduce fever + pain
š· Anti-inflammatory effect reduces tissue swelling
š· Peripheral sensitization decreases with prostaglandin block
š· No respiratory depression risk
š· Ceiling effect limits maximum analgesia
š Clinical Use
š· Mild to moderate pain first-line therapy
š· Postoperative incisional pain management
š· Musculoskeletal inflammation treatment
š· Fever reduction antipyretic effect
š· Adjunct with opioids in multimodal therapy
š· Useful in opioid-sparing protocols
𩺠Nursing Monitoring
š· Monitor GI irritation risk with NSAIDs
š· Assess renal function creatinine ā caution
š· Avoid high doses acetaminophen >4g/day
š· Evaluate liver function ALT AST elevation
š· Monitor bleeding risk platelet inhibition
š· Educate patient avoid duplicate OTC dosing
š Medication Examples
š· Ibuprofen anti-inflammatory mild pain control
š· Ketorolac short-term postoperative analgesic
š· Acetaminophen central analgesic antipyretic
š· Celecoxib COX-2 selective lower GI risk
š· Naproxen longer duration NSAID
š· Diclofenac topical reduces localized inflammation
7ļøā£ š„ Opioid Pharmacology & Receptor Mechanisms
𧬠Mechanism of Action
š· Bind mu receptors in CNS spinal cord
š· Inhibit ascending pain transmission pathway
š· Activate descending inhibitory pathways
š· Reduce neurotransmitter release substance P
š· Produce analgesia sedation euphoria
š· Dose-dependent respiratory depression risk
š Clinical Use
š· Moderate to severe acute pain
š· Postoperative severe incisional pain
š· Cancer-related severe pain management
š· Breakthrough pain short-acting agents
š· Adjunct in anesthesia induction
š· Palliative care symptom control
𩺠Nursing Monitoring
š· Respiratory rate <12/min concerning
š· Sedation scale identifies oversedation early
š· Monitor BP hypotension possible
š· Assess bowel function constipation risk
š· Monitor nausea vomiting common effect
š· Reassess pain 30ā60 minutes post dose
š Medication Examples
š· Morphine standard strong opioid
š· Fentanyl rapid onset short duration
š· Hydromorphone potent alternative option
š· Oxycodone oral moderate-severe pain
š· Tramadol weak opioid dual mechanism
š· Naloxone opioid antagonist reversal agent
8ļøā£ š„ Adjuvant & Co-Analgesic Medications
𧬠Mechanism of Action
š· Target neuropathic pain pathways not nociceptive only
š· Modulate neurotransmitters serotonin + norepinephrine
š· Stabilize nerve membranes ā ectopic firing
š· Enhance descending inhibitory pathways
š· Reduce central sensitization mechanisms
š· Improve analgesia when combined with opioids
š Clinical Use
š· Neuropathic pain diabetic neuropathy shingles
š· Chronic back pain with nerve component
š· Cancer-related neuropathic pain
š· Fibromyalgia widespread musculoskeletal pain
š· Adjunct for opioid-resistant pain
š· Reduce opioid dose requirement
𩺠Nursing Monitoring
š· Monitor sedation dizziness risk falls
š· Assess mood changes with antidepressants
š· Check renal function for gabapentin dosing
š· Watch for serotonin syndrome signs
š· Evaluate pain relief after titration
š· Educate patient delayed onset effect
š Medication Examples
š· Gabapentin neuropathic pain modulation
š· Pregabalin nerve pain stabilizer
š· Duloxetine SNRI chronic pain
š· Amitriptyline TCA neuropathic relief
š· Carbamazepine trigeminal neuralgia treatment
š· Lidocaine patch localized neuropathic pain
9ļøā£ š„ Multimodal Analgesia Principles
𧬠Rationale
š· Combines different mechanisms for synergistic effect
š· Targets peripheral + central pain pathways
š· Reduces opioid requirement and side effects
š· Improves overall analgesic effectiveness
š· Prevents central sensitization escalation
š· Supports enhanced recovery protocols
š Clinical Application
š· NSAID + opioid combination common postoperative
š· Acetaminophen scheduled around-the-clock dosing
š· Regional block + systemic analgesic integration
š· Adjuvant added for neuropathic component
š· Non-pharmacologic therapy included routinely
š· Early intervention prevents severe escalation
𩺠Nursing Responsibilities
š· Administer medications on scheduled basis
š· Monitor for cumulative side effects
š· Assess pain relief using consistent scale
š· Coordinate timing with mobilization
š· Educate patient on purpose of combination therapy
š· Report uncontrolled pain despite multimodal plan
š Example Combinations
š· Morphine + ketorolac postoperative regimen
š· Acetaminophen + oxycodone oral therapy
š· Epidural bupivacaine + fentanyl infusion
š· Gabapentin + NSAID chronic pain
š· Lidocaine patch + acetaminophen localized pain
š· Cold therapy + opioid for incisional pain
š š„ Patient-Controlled Analgesia (PCA)
𧬠Mechanism
š· Delivers preset opioid dose IV route
š· Lockout interval prevents overdose
š· Basal rate optional continuous infusion
š· Empowers patient control of pain
š· Reduces delay between pain and treatment
š· Maintains stable plasma opioid level
š Clinical Indications
š· Moderate to severe postoperative pain
š· Patients able to understand instructions
š· Cancer pain requiring titration
š· Major abdominal or orthopedic surgery
š· Avoids peaks and troughs in dosing
š· Preferred when frequent PRN needed
𩺠Nursing Monitoring
š· Respiratory rate monitored frequently
š· Sedation scale assessed every 1ā2 hrs
š· Verify only patient presses button
š· Monitor total dose delivered each shift
š· Assess IV site patency regularly
š· Evaluate pain relief effectiveness
š Common PCA Medications
š· Morphine standard PCA opioid
š· Hydromorphone alternative stronger potency
š· Fentanyl short-acting IV opioid
š· Naloxone available for reversal
š· Ondansetron prevents opioid-induced nausea
š· Stool softener prevents constipation
1ļøā£1ļøā£ š„ Epidural & Regional Pain Control
𧬠Mechanism
š· Local anesthetic blocks nerve conduction
š· Opioid in epidural enhances analgesia
š· Reduces systemic opioid requirement
š· Interrupts transmission at spinal level
š· Provides segmental pain relief
š· Maintains patient consciousness
š Clinical Use
š· Major abdominal surgery pain control
š· Thoracic surgery analgesia
š· Obstetric labor analgesia
š· Lower extremity orthopedic procedures
š· Chronic cancer pain management
š· Enhanced recovery surgical protocols
𩺠Nursing Monitoring
š· Monitor BP hypotension risk
š· Assess motor strength return
š· Check sensory level dermatome spread
š· Inspect catheter insertion site redness
š· Monitor urinary retention incidence
š· Assess respiratory depression if opioid included
š Medication Examples
š· Bupivacaine long-acting local anesthetic
š· Ropivacaine sensory block with less motor effect
š· Fentanyl epidural opioid adjunct
š· Morphine intrathecal prolonged analgesia
š· Phenylephrine treats hypotension
š· Lipid emulsion treats toxicity rare
1ļøā£2ļøā£ š„ Opioid Safety & Monitoring
𧬠Risk Factors
š· Elderly patients ā drug metabolism
š· Renal impairment ā drug accumulation
š· Sleep apnea ā respiratory depression risk
š· Obesity affects drug distribution
š· Concurrent sedatives ā CNS depression
š· High opioid dose increases overdose probability
š Early Warning Signs
š· Sedation increasing before RR decline
š· Pinpoint pupils classic opioid effect
š· Shallow breathing concerning sign
š· Decreased responsiveness to verbal stimuli
š· Oxygen saturation gradually decreasing
š· Snoring respirations may indicate obstruction
𩺠Nursing Monitoring
š· Respiratory rate assessed every 1ā2 hrs
š· Sedation scale documented consistently
š· Continuous pulse oximetry high-risk patients
š· Capnography detects early hypoventilation
š· Reassess after dose escalation
š· Educate family avoid pressing PCA
š Safety Interventions
š· Naloxone IV reverses opioid effects
š· Oxygen supplementation if desaturation
š· Reduce or hold opioid dose
š· Stimulate patient encourage deep breathing
š· Notify provider for persistent depression
š· Document response after reversal agent
1ļøā£3ļøā£ š„ Opioid-Induced Adverse Effects
𧬠Pathophysiology
š· Mu receptor activation ā respiratory center sensitivity
š· Decreased GI motility causes constipation
š· CNS depression leads to sedation
š· Histamine release may cause itching
š· Chemoreceptor trigger zone activation causes nausea
š· Parasympathetic suppression leads to urinary retention
š Clinical Manifestations
š· Respiratory rate <12/min concerning finding
š· Excessive drowsiness difficult to arouse
š· Constipation no bowel movement >3 days
š· Nausea vomiting early therapy common
š· Pruritus especially with morphine use
š· Urinary retention bladder distention discomfort
𩺠Nursing Assessment
š· Monitor respiratory rate depth pattern
š· Assess sedation using standardized scale
š· Check bowel sounds abdominal distention
š· Monitor intake and output carefully
š· Ask about nausea intensity regularly
š· Inspect skin for scratching irritation
š Management Strategies
š· Naloxone reverses severe respiratory depression
š· Stool softeners (docusate) prevent constipation
š· Antiemetics (ondansetron) control nausea
š· Antihistamines reduce pruritus symptoms
š· Dose reduction if oversedation observed
š· Encourage hydration + mobility for bowel motility
1ļøā£4ļøā£ š„ Non-Pharmacologic Pain Interventions
𧬠Physiologic Basis
š· Stimulate large fibers closing spinal gate theory
š· Reduce sympathetic activation stress response
š· Increase endorphin release naturally
š· Improve circulation to injured tissues
š· Decrease muscle tension contributing pain
š· Enhance patient sense of control
š Clinical Applications
š· Cold therapy ā inflammation acute injury
š· Heat therapy relaxes muscle spasm
š· Positioning reduces incisional tension
š· Splinting incision during coughing reduces pain
š· Massage promotes relaxation response
š· Music therapy decreases anxiety perception
𩺠Nursing Implementation
š· Apply ice 15ā20 minutes intervals
š· Assess skin integrity before heat use
š· Educate proper splinting technique
š· Encourage deep breathing exercises
š· Combine with medication for synergy
š· Evaluate effectiveness after intervention
š Integration with Medical Therapy
š· Use before opioid dose escalation
š· Reduce total opioid requirement
š· Useful in mild to moderate pain
š· Effective adjunct in chronic pain
š· Safe for elderly patients
š· Supports multimodal analgesia plan
1ļøā£5ļøā£ š„ Pain in Special Populations
šµ Elderly Patients
š· Altered pharmacokinetics ā metabolism clearance
š· Increased sensitivity to opioids sedation risk
š· Atypical pain presentation possible
š· Higher fall risk with dizziness
š· Start low go slow dosing principle
š· Monitor renal function for drug adjustment
š¶ Pediatric Patients
š· Use weight-based dosing calculations
š· FLACC scale for nonverbal children
š· Fear increases perceived pain intensity
š· Parental presence improves comfort
š· Avoid codeine respiratory depression risk
š· Assess behavior changes indicating discomfort
𩺠Renal or Hepatic Impairment
š· Reduced clearance ā drug accumulation
š· Avoid NSAIDs in renal dysfunction
š· Adjust opioid dose if creatinine ā
š· Monitor liver enzymes with acetaminophen
š· Prefer short-acting agents careful titration
š· Frequent reassessment prevents toxicity
š§ Cognitive Impairment
š· May underreport pain verbally
š· Observe nonverbal cues agitation
š· Use simplified pain scale tools
š· Avoid oversedation confusion worsening
š· Caregiver input valuable assessment
š· Regular reassessment essential
1ļøā£6ļøā£ š„ Chronic Pain & Central Sensitization
𧬠Pathophysiology
š· Persistent stimulation ā dorsal horn excitability
š· NMDA receptor activation enhances signal transmission
š· Lower pain threshold hyperalgesia develops
š· Allodynia pain from nonpainful stimulus
š· Neuroplastic changes maintain pain without injury
š· Psychological stress perpetuates sensitization
š Clinical Presentation
š· Pain persists beyond tissue healing
š· Widespread pain disproportionate to findings
š· Fatigue + sleep disturbance common
š· Mood disorders frequently coexist
š· Increased sensitivity to touch
š· Reduced functional capacity
𩺠Nursing Assessment
š· Evaluate duration >3 months chronic
š· Screen depression anxiety symptoms
š· Assess coping strategies used
š· Identify impact on daily function
š· Evaluate medication adherence
š· Monitor opioid tolerance development
š Management Approach
š· Multimodal long-term therapy required
š· Adjuvants (duloxetine, gabapentin) preferred
š· Limit long-term opioid dependence
š· Cognitive behavioral therapy beneficial
š· Physical therapy improves function
š· Encourage gradual activity pacing
1ļøā£7ļøā£ š„ Cancer Pain Management
𧬠Mechanism
š· Tumor invasion compresses nerves tissues
š· Bone metastasis causes severe nociceptive pain
š· Chemotherapy may induce neuropathic pain
š· Inflammatory mediators amplify signal transmission
š· Mixed pain types common presentation
š· Progressive disease increases intensity
š Clinical Features
š· Persistent baseline pain daily
š· Breakthrough episodes sudden severe flare
š· Nighttime worsening frequent complaint
š· Emotional distress intensifies perception
š· Functional decline common
š· Appetite disturbance due discomfort
𩺠Nursing Assessment
š· Use consistent scale each shift
š· Identify breakthrough vs baseline pain
š· Monitor opioid tolerance escalation
š· Assess bowel function constipation risk
š· Evaluate psychosocial support system
š· Reassess after each titration
š WHO Pain Ladder Approach
š· Step 1 non-opioid mild pain
š· Step 2 weak opioid moderate pain
š· Step 3 strong opioid severe pain
š· Adjuvants added at any step
š· Around-the-clock dosing preferred
š· Rescue dose for breakthrough pain
1ļøā£8ļøā£ š„ Breakthrough Pain & Escalation
𧬠Mechanism
š· Sudden flare despite controlled baseline
š· Often triggered by movement or activity
š· Rapid onset short duration pattern
š· Occurs in chronic or cancer pain
š· May indicate disease progression
š· Insufficient baseline analgesia possible
š Clinical Features
š· Intensity spike above baseline rating
š· Predictable with certain activities
š· Episodes last 30ā60 minutes
š· Causes functional interruption
š· Anxiety anticipation may worsen
š· Requires rapid-acting relief
𩺠Nursing Assessment
š· Identify trigger pattern clearly
š· Differentiate from end-of-dose failure
š· Document frequency per day
š· Assess response to rescue dose
š· Evaluate adherence baseline schedule
š· Notify provider if frequent episodes
š Management
š· Short-acting opioid (fentanyl, morphine IR)
š· Dose typically 10ā15% daily total opioid
š· Adjust baseline if frequent episodes
š· Non-pharmacologic support during activity
š· Educate patient on rescue timing
š· Monitor sedation after rescue dose
1ļøā£9ļøā£ š„ Ethical Issues & Barriers in Pain Management
āļø Ethical Principles
š· Pain relief fundamental patient right
š· Autonomy supports patient self-report
š· Beneficence requires adequate control
š· Nonmaleficence avoid overtreatment harm
š· Justice ensures equal access care
š· Respect cultural pain expression differences
š§ Common Barriers
š· Fear of addiction limits opioid use
š· Provider bias underestimates pain severity
š· Regulatory restrictions opioid prescribing
š· Patient reluctance report pain
š· Misconceptions tolerance vs addiction
š· Language barriers reduce communication
𩺠Nursing Role
š· Advocate for adequate pain control
š· Educate about addiction vs dependence
š· Clarify myths about opioid use
š· Promote safe monitoring practices
š· Encourage honest pain reporting
š· Document objective assessment findings
š Safe Practice Balance
š· Use lowest effective opioid dose
š· Combine multimodal therapies
š· Monitor closely for misuse signs
š· Utilize pain contracts if needed
š· Regular reassessment prevents undertreatment
š· Balance relief with safety monitoring
2ļøā£0ļøā£ š„ Complex & Refractory Pain Management
𧬠Mechanism
š· Pain persists despite standard therapy
š· Mixed nociceptive + neuropathic components
š· Central sensitization complicates treatment
š· Psychological factors amplify perception
š· Tolerance reduces opioid effectiveness
š· Multisystem involvement possible
š Clinical Features
š· High pain score despite medication
š· Frequent breakthrough episodes
š· Functional decline progressive
š· Emotional distress prominent
š· Sleep severely disrupted
š· Reduced quality of life
𩺠Nursing Assessment
š· Comprehensive reassessment entire pain profile
š· Evaluate adherence medication schedule
š· Assess substance misuse risk
š· Consult pain management specialist
š· Monitor side effects limiting therapy
š· Identify new pathology or complication
š Advanced Management
š· Opioid rotation improves responsiveness
š· Add NMDA antagonist (ketamine) refractory cases
š· Interventional blocks nerve ablation procedures
š· Implantable pumps chronic severe pain
š· Multidisciplinary pain clinic referral
š· Integrate psychological therapy support
Effective pain management requires systematic assessment, individualized therapy, and vigilant monitoring for safety. Nurses play a central role in balancing adequate analgesia with prevention of adverse effects and misuse. Multimodal approaches combining pharmacologic and non-pharmacologic interventions provide the most effective and safest outcomes. Mastery of pain principles strengthens clinical judgment and improves quality of life for both acute and chronic care patients.

Comments